BioDiscovery News

Featured Post

BioDiscovery launches NxClinical 4.1, a comprehensive system allowing interpretation of variants of any size from SNVs to large CNVs

NxClinical 4.1 is a unique software solution for integration of copy number, sequence variants, and allelic changes obtained from microarray and NGS technologies. NxClinical 4.1 allows combined analysis and interpretation of all genomic variants on a single, platform agnostic system.

Featured Post

BioDiscovery Inc. Forms Partnership with Be Creative Lab (Beijing) Co. Ltd. For Distribution of NxClinical Software

BioDiscovery announced today an agreement with Be Creative Lab in Beijing, China to be the exclusive reseller and distributor of BioDiscovery products in China.

Featured Post

BioDiscovery releases Nexus Copy Number 9.0 with improved copy number estimation from NGS, including targeted panels and shallow sequencing

The new features in Nexus Copy Number 9.0 really enhance the usability of WES, WGS, targeted panels and low-pass sequencing for copy number analysis.

Featured Post

GENALICE and BioDiscovery Partner to Empower Rapid NGS Data Interpretation

GENALICE and BioDiscovery announce a co-marketing partnership to offer their products together as a turn-key end-to-end solution for the use of next-generation sequencing (NGS) data to interpret genomes.

Featured Post

Ambry Genetics Selects BioDiscovery’s NxClinical Software for Analysis, Management, and Reporting of Copy Number Events in its Clinical Genomics Workflow

Ambry Genetics selects BioDiscovery’s NxClinical software for analysis, management, and reporting of copy number events in its clinical genomics workflow.

BioDiscovery launches NxClinical 4.1, a comprehensive system allowing interpretation of variants of any size from SNVs to large CNVs

NxClinical 4.1 is a unique software solution for integration of copy number, sequence variants, and allelic changes obtained from microarray and NGS technologies. NxClinical 4.1 allows combined analysis and interpretation of all genomic variants on a single, platform agnostic system.

Thermo Fisher Scientific and BioDiscovery form software development partnership providing an end-to-end solution for cancer researchers

BioDiscovery, a leader in copy number analysis software, created a new tailored software solution (Nexus Express for OncoScan) for copy number detection and downstream analysis for the OncoScan™ CNV Assay. The assay plus software solution allows researchers performing solid tumor analysis a high-quality, complete, end-to-end solution from raw data to discovery for difficult FFPE samples.

BioDiscovery Inc. Forms Partnership with Be Creative Lab (Beijing) Co. Ltd. For Distribution of NxClinical Software

BioDiscovery announced today an agreement with Be Creative Lab in Beijing, China to be the exclusive reseller and distributor of BioDiscovery products in China.

BioDiscovery launches NxClinical 4.0, a unique system allowing analysis and interpretation of CNV, SNV, and AOH from a single NGS assay

BioDiscovery launches NxClinical 4.0, a unique system allowing analysis and interpretation of CNV, SNV, and AOH from a single NGS assay.

BioDiscovery releases Nexus Copy Number 9.0 with improved copy number estimation from NGS, including targeted panels and shallow sequencing

The new features in Nexus Copy Number 9.0 really enhance the usability of WES, WGS, targeted panels and low-pass sequencing for copy number analysis.

GENALICE and BioDiscovery Partner to Empower Rapid NGS Data Interpretation

GENALICE and BioDiscovery announce a co-marketing partnership to offer their products together as a turn-key end-to-end solution for the use of next-generation sequencing (NGS) data to interpret genomes.

BioDiscovery to announce NxClinical 3.0, a new software to unite data from arrays and NGS, at ASHG 2016

NxClinical 3.0 will be launched during the ASHG 2016 Meeting, October 18-21 in Vancouver, BC, Canada

Ambry Genetics Selects BioDiscovery’s NxClinical Software for Analysis, Management, and Reporting of Copy Number Events in its Clinical Genomics Workflow

Ambry Genetics selects BioDiscovery’s NxClinical software for analysis, management, and reporting of copy number events in its clinical genomics workflow.

Illumina Selects BioDiscovery’s NxClinical Software for Data Visualization, Management and Interpretation for its CytoSeq™ assay, an NGS-based Solution for Detection of CNVs, AOH, and SNVs

Illumina Selects BioDiscovery’s NxClinical Software for Data Visualization, Management and Interpretation for its CytoSeq ™ assay, an NGS-based Solution for Detection of CNVs, AOH, and SNVs

BioDiscovery releases Nexus Copy Number 8.0 with cutting-edge features: estimation of copy number and allelic events from NGS data

Nexus Copy Number 8.0 is derivation of copy number from NGS results. BAM (pooled reference), detects copy number from WES, WGS, and targeted NGS panels.